Table 1.
Chemotherapy and radiation protocol for study participants
| ID no. | TNM | XRT type | Total XRT dose | Chemo |
|---|---|---|---|---|
| 1 | T4N1 | Conventional | 7,020 | Cisplatin/etoposide |
| 2 | T3N2b | Conventional | 7,020 | 2× cisplatin/5FU |
| 3 | T3N2c | Conventional | 7,000 | 2× cisplatin/5FU |
| 4 | T1N1 | Conventional | 7,200 | 1× cisplatin/5FU |
| 5 | T2N0 | Conventional | 7,000 | 2× carbo/5FU |
| 6 | T3N2 | Conventional | 7,020 | 2× cisplatin/5FU |
| 7 | T3N2b | Conventional | 5,400a | 2× cisplatin/5FU |
| 8 | T1N2b | Conventional | 7,200 | 2× cisplatin/5FU |
| 9 | T4N1 | Conventional | 7,380 | 2× cisplatin/5FU |
| 10 | T2N1 | Conventional | 7,000 | 2× cisplatin/5FU |
| 11 | T4N1 | Conventional | 7,020 | 2× cisplatin/5FU |
| 12 | T4N3 | Conventional | 7,020 | 2× cisplatin/5FU |
| 13 | T4N1 | Conventional | 7,560 | 3× cisplatin |
| 14 | T3N3 | Conventional | NA | NA |
| 15 | T4N0 | Conventional | NA | NA |
| 16 | T4N0 | Conventional | 7,020 | 2× cisplatin/5FU |
| 17 | T4N3 | IMRT | 7,000 | 2× cisplatin |
| 18 | T2N0 | IMRT | 7,000 | 2× cisplatin |
| 19 | T2N2a | IMRT | 7,000 | 3× cisplatin/5FU |
| 20 | T1N2b | IMRT | 7,000 | 2× cisplatin/5FU |
| 21 | T2N1 | IMRT | 7,000 | 2× cisplatin |
| 22 | T2N2 | IMRT | 6,800 | 3× cisplatin |
| 23 | T2N0 | IMRT | 7,000 | 2× cisplatin |
| 24 | T2N2b | IMRT | 7,000 | 4× cisplatin |
| 25 | T4N3 | IMRT | 7,000 | 2× cisplatin |
| 26 | T3N2 | IMRT | 6,800 | ERBITUX |
| 27 | T1N2b | IMRT | 7,000 | 2× cisplatin |
| 28 | T3N2b | IMRT | 7,000 | 2× cisplatin |
| 29 | T2N0 | IMRT | 6,800 | None |
| 30 | T3N1 | IMRT | 6,800 | 2× cisplatin |
NA records not available, 5FU 5 fluorouracil, carbo carboplatin
aPatient moved from area before finishing treatment